Clinical trials
Terminated Glomerulosclerosis, Focal Segmental trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Goldfinch Bio, Inc. | 2 |
| Amgen | 1 |
| Aurinia Pharmaceuticals Inc. | 1 |
| Columbia University | 1 |
| Kyntra Bio | 1 |
| Northwell Health | 1 |
| Pfizer | 1 |
| Tenet Medicines | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glomerulosclerosis, Focal Segmental | 9 |
| Diabetic Nephropathies | 3 |
| Nephrosis, Lipoid | 3 |
| Proteinuria | 2 |
| Diabetes Complications | 1 |
| Diabetes Mellitus | 1 |
| Endocrine System Diseases | 1 |
| Glomerulonephritis | 1 |
| Glomerulonephritis, IGA | 1 |
| Glomerulonephritis, Membranous | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.